© Associated PressGraph shows incidence rates for prostate cancer between 1975 and 2006 and highest death rates from prostate cancer by race between 2001 and 2006.
Atlanta - Months after experts discounted the importance of routine mammograms and Pap smears for many women, the American Cancer Society is warning more explicitly than ever that regular testing for prostate cancer is of questionable value, too, and
can do men more harm than good.The cancer society has not recommended routine screening for most men since the mid-1990s, and that is not changing. But the organization is urging doctors to talk frankly with their patients about the risks and limitations of the PSA blood test when offering it.
The widely used test often spots cancers too slow-growing to be deadly, and treatment can lead to incontinence and impotence. Two big studies last year suggested prostate cancer screening doesn't necessarily save lives, and any benefits can come at a high price.
Some doctors and advocates are troubled by the new guidelines.
"Prostate cancer is still something to be respected if not feared, and we still need to be vigilant. I hope primary care docs or insurance companies don't use the 'softening' of the guidelines as an excuse to not do screening at all," said Dr. David Roberts, medical director of an Atlanta clinic that caters to businessmen.